MITO7
Trial Description:
First line weekly carboplatin and paclitaxel versus every 3 weeks carboplatin/paclitaxel in patients with ovarian cancer: phase III multicentre trial
Lead Cooperative Group:
Trial Number:
Disease Site:
Ovarian
Trial Status:
Completed
Contact person:
spignata